All News

CHICAGO -- Pemetrexed (Alimta) plus platinum chemotherapy for advanced non-small cell lung cancer (NSCLC) may reduce toxicity compared with a gemcitabine (Gemzar) and platinum doublet but hold little other advantage.

CHICAGO -- A shorter lead-in time between recommended vitamin B12 supplementation and pemetrexed (Alimta) therapy may reduce treatment delays without impairing its efficacy.

PHILADELPHIA -- Magnets and batteries may cause serious harm if swallowed, necessitating endoscopic or surgical removal.

PHILADELPHIA -- An average of 15 in-flight medical emergencies happen on domestic flights every day in the United States, according to estimates from the Federal Aviation Administration (FAA).

SAN DIEGO -- Men older than 50 with androgen deficiency are at a greater risk for all-cause mortality than their peers with age-appropriate testosterone, reported investigators here.

CHICAGO, June 5 -- Targeted therapy missed the mark as maintenance therapy for small-cell lung cancer, researchers reported here.

CHICAGO -- Cetuximab (Erbitux) added to first-line chemotherapy for metastatic colorectal cancer lengthens progression-free survival by about a month, researchers found.

CHICAGO -- Recurrence rates for resectable liver metastases from colorectal cancer are lower when adjuvant and neoadjuvant chemotherapy augment surgery, researchers said here.

CHICAGO -- Parents of children with cancer gain hope from information about the prognosis, even when the outlook is poor, according to a survey.

CHICAGO -- Arsenic trioxide (Trisenox) improves survival for acute promyelocytic leukemia when added to first-line treatment, researchers found.

CHICAGO -- Radium-223, an investigational bone-seeking radioisotope, appeared to slow progression of skeletal metastases in hormone-refractory prostate cancer, researchers reported here.

KINGSTON, Ontario -- Using antipsychotic drugs to treat patients with dementia may be fatal, according to researchers here.

ROCHESTER, N.Y. -- Surgery for intractable temporal lobe epilepsy may cause a decline in verbal recall memory in about a third of patients, but the opportunity to end seizures may be worth the risk, investigators here said.

CHICAGO -- Oxaliplatin (Eloxatin)-containing chemotherapy boosts overall survival for stage III colon cancer, with a hint of benefit for high-risk stage II disease as well, according to large randomized trial.

BOSTON -- Suicidal tendencies that arise in some men who start on the antidepressant citalopram (Celexa) may be linked to genetic mutations, investigators in Boston and Dallas reported.

CHICAGO -- Neoadjuvant chemotherapy did not improve survival of patients with resectable non-small cell lung cancer (NSCLC) compared with surgery alone, researchers reported here.

OTTAWA, Ontario -- Men ought to swear off cigarettes long before they even think of having children, according to researchers here.

CHICAGO -- Localized prostate cancer needs a balanced view of treatment options from both urologists and radiologists, researchers said here.